Clinical trial
Reducing Systemic Inflammation in People on Antiretroviral Therapy
NCT07030920 is registered in ClinicalTrials.gov with Centre hospitalier de l'Université de Montréal (CHUM) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Reducing Systemic Inflammation in People on Antiretroviral Therapy
- Lead sponsor
- Centre hospitalier de l'Université de Montréal (CHUM)
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- September 30, 2025
- Completion date
- January 31, 2029
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular risk factor, human immunodeficiency virus (hiv)